Stay updated on Pembrolizumab vs. EDP1503 in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs. EDP1503 in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs. EDP1503 in Melanoma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Recruitment status now indicates no participants are being sought, and new guidance sections were added to help users read the study record and join the study. The revision tag was updated to v3.6.0 and the Intervention/Treatment heading formatting was adjusted.
    Difference
    0.6%
    Check dated 2026-06-13T01:31:43.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.5.4 to v3.5.5, indicating a minor update to the page version.
    Difference
    0.1%
    Check dated 2026-06-05T23:55:57.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    - The page now displays Revision: v3.5.4, replacing v3.5.3. This indicates a version update to the page's revision metadata.
    Difference
    0.1%
    Check dated 2026-05-15T15:29:51.000Z thumbnail image
  5. Check
    60 days ago
    Change Detected
    Summary
    The page’s interface/release revision updated from **v3.5.2** to **v3.5.3**.
    Difference
    0.1%
    Check dated 2026-04-24T05:40:39.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    Revision: v3.5.2 replaces v3.5.0 on the page.
    Difference
    0.1%
    Check dated 2026-04-16T21:35:21.000Z thumbnail image
  7. Check
    96 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-18T23:58:48.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs. EDP1503 in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs. EDP1503 in Melanoma Clinical Trial page.